MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MP-10-0001215
S.V.Biovac Pharmaceuticals Pvt Ltd
S.V.Biovac Pharmaceuticals Pvt Ltd - pharma in Bhopal, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹79,476
▼ 98% YoY
Net loss · FY 2025
₹2.35 Lakh
Net margin -295.8%
EBITDA · FY 2025
-₹3.1 Lakh
EBITDA margin -390.2%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1.01 Lakh
Issued & subscribed
Company age
32 yrs
Est. 1994
Employees · EPFO
1
Provident fund records
Directors on board
3
As per MCA filings
About S.V.Biovac Pharmaceuticals Pvt Ltd
Data last updated:
S.V.Biovac Pharmaceuticals Pvt Ltd is a private limited company based in Bhopal, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 January 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP1994PTC008065. Its GSTIN is 23AAECS5028F1ZO (Madhya Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.01 Lakh. It is led by directors including Hitesh Kumbhare and Bharti Kumbhare.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No 1 Chhatr Shakti Bhawan Depot Square Bhadbhada Road Bhopal Mp 462003 In, Madhya Pradesh, India – 462003.
As per the financials filed for FY 2025, the company reported a revenue of ₹79,476, a decline of 98% compared to the previous year. For the same year it recorded a net loss of ₹2.35 Lakh (net margin -295.8%) and EBITDA of -₹3.1 Lakh (EBITDA margin -390.2%). Revenue has declined at a compounded annual rate (CAGR) of 75% over three years and 43% over five years.
The company has about 1 employee on its provident fund (EPFO) records.
S.V.Biovac Pharmaceuticals Pvt Ltd is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-10-0001215). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232MP1994PTC008065
Registration Number 008065
Incorporation Date 18 January 1994
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MP-10-0001215
Recognitions & Rankings of S.V.Biovac Pharmaceuticals
Contact details
S.V.Biovac Pharmaceuticals Pvt Ltd's registered office is in Bhopal, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No 1 Chhatr Shakti Bhawan Depot Square Bhadbhada Road Bhopal Mp 462003 In, Madhya Pradesh, India – 462003
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of S.V.Biovac Pharmaceuticals Pvt Ltd, buy the company report.
Comprehensive company report
S.V.Biovac Pharmaceuticals Pvt Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of S.V.Biovac Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of S.V.Biovac Pharmaceuticals Pvt Ltd, buy the company report.
Financials of S.V.Biovac Pharmaceuticals Pvt Ltd
FY 2025 filings availableS.V.Biovac Pharmaceuticals Pvt Ltd reported revenue of ₹79,476 (down 98% YoY) for FY 2025.
Revenue · FY 2025
₹79,476 ▼ 98%
Net loss · FY 2025
₹2.35 Lakh margin -295.8%
EBITDA · FY 2025
-₹3.1 Lakh margin -390.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 98%
3 years · compounded
▼ 75%
5 years · compounded
▼ 43%
EBITDA CAGR growth
1 year
▼ 9%
3 years · compounded
▲ 1%
5 years · compounded
▲ 18%
Revenue has declined at a compounded annual rate (CAGR) of 43% over five years, including a 98% fall in the latest year. EBITDA fell 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.1 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.35 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -390.2% | ||||
| Net Profit Margin | -295.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of S.V.Biovac Pharmaceuticals Pvt Ltd, buy the company report.
Board of directors of S.V.Biovac Pharmaceuticals Pvt Ltd
S.V.Biovac Pharmaceuticals has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hitesh Kumbhare Also directs: Healpros Biomedicals Private Limited | Director | 23 Jan 2020 | 6 Years 9 Months | Current |
| Bharti Kumbhare | Director | 23 Jan 2020 | 6 Years 9 Months | Current |
| Vijay Athwal | Director | 23 Jan 2020 | 6 Years 9 Months | Current |
Peer comparison
S.V.Biovac Pharmaceuticals Pvt Ltd is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zexo Pharmaceuticals Private Limited | ₹80,886 (FY 2019) | Noida, Uttar Pradesh, India | ||||
| Bilchem Biotec Private Limited | ₹80,865 (FY 2023) | -38.0% | Shimla, Himachal Pradesh, India | |||
| Ranofy Biotech Private Limited | ₹80,510 (FY 2025) | -94.0% | Ambala, Haryana, India | |||
| Orthis Healthcare Private Limited | ₹79,542 (FY 2025) | -62.0% | New Delhi, Delhi, India | |||
| S.V.Biovac Pharmaceuticals Pvt Ltdthis company | ₹79,476 (FY 2025) | -₹2.35 Lakh | -295.8% | -98.0% | 1 | Bhopal, Madhya Pradesh, India |
| Shoundik Pharmaceuticals Private Limited | ₹78,708 (FY 2024) | Delhi, India |
To see the full peer comparison of S.V.Biovac Pharmaceuticals Pvt Ltd, buy the company report.
Auditor
S.V.Biovac Pharmaceuticals Pvt Ltd is audited by S.S.U AND ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.S.U AND ASSOCIATES | FY 2022 | 003659C |
Shareholding
The shareholding of S.V.Biovac Pharmaceuticals Pvt Ltd is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of S.V.Biovac Pharmaceuticals Pvt Ltd, buy the company report.
Legal cases
No court or tribunal cases involving S.V.Biovac Pharmaceuticals Pvt Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
S.V.Biovac Pharmaceuticals Pvt Ltd has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 2 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (2 of 2)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Riemann Labs Private Limited | |||
| M/S Vishal Pharmaceuticals Laboratories |
To see the full MSME payment records of S.V.Biovac Pharmaceuticals Pvt Ltd, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
S.V.Biovac Pharmaceuticals Pvt Ltd has a workforce of 1 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
1
Active EPFO establishments
1
GST
S.V.Biovac Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAECS5028F1ZO | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of S.V.Biovac Pharmaceuticals Pvt Ltd, buy the company report.
Recent activity
S.V.Biovac Pharmaceuticals Pvt Ltd has 9 board changes on record since 2008: 3 appointments and 6 cessations. The latest: Bharti Kumbhare ceased to be Additional Director on 30 Dec 2020.
AGM
S.V.Biovac Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
S.V.Biovac Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Ceased
Bharti Kumbhare ceased to be Additional Director.
Ceased
Hitesh Kumbhare ceased to be Additional Director.
Ceased
Vijay Athwal ceased to be Additional Director.
Ceased
Sadanand Ingle ceased to be Director.
Ceased
Sangeeta Ingle ceased to be Whole-Time Director.
Appointed
Bharti Kumbhare was appointed as Director.
Appointed
Hitesh Kumbhare was appointed as Director.
Appointed
Vijay Athwal was appointed as Director.
Ceased
Vivek Untwale ceased to be Director.
Incorporation
18 Jan 1994
S.V.Biovac Pharmaceuticals Pvt Ltd was registered on 18 Jan 1994 with Roc Gwalior & aged 32 years 9 months as per MCA records.
Frequently asked questions
S.V.Biovac Pharmaceuticals is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 January 1994 (32+ years old) and is registered under CIN U24232MP1994PTC008065.
S.V.Biovac Pharmaceuticals has 3 current directors:
- Hitesh Kumbhare - Director
- Bharti Kumbhare - Director
- Vijay Athwal - Director
The latest financial statements of S.V.Biovac Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of S.V.Biovac Pharmaceuticals is 23AAECS5028F1ZO, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of S.V.Biovac Pharmaceuticals is U24232MP1994PTC008065. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
S.V.Biovac Pharmaceuticals was incorporated on 18 January 1994, making it 32+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of S.V.Biovac Pharmaceuticals by revenue are Zexo Pharmaceuticals Private Limited, Bilchem Biotec Private Limited, Ranofy Biotech Private Limited, Orthis Healthcare Private Limited, Shoundik Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Bharti Kumbhare ceased to be Additional Director on 30 Dec 2020. Hitesh Kumbhare ceased to be Additional Director on 30 Dec 2020. Vijay Athwal ceased to be Additional Director on 30 Dec 2020. S.V.Biovac Pharmaceuticals has 9 board changes on record in total.
Yes, S.V.Biovac Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-10-0001215).
S.V.Biovac Pharmaceuticals has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 2 overdue payments to 2 micro and small suppliers. The latest return was filed on 29 May 2019.
The registered office of S.V.Biovac Pharmaceuticals is at Shop No 1 Chhatr Shakti Bhawan Depot Square Bhadbhada Road Bhopal Mp 462003 In, Madhya Pradesh, India – 462003.
S.V.Biovac Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages